Global Biopharmaceutical Contract Manufacturing Market Research Report 2022

Global Biopharmaceutical Contract Manufacturing Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Growth Factors
1.2.3 Interferons
1.2.4 Monoclonal Antibodies
1.2.5 Recombinant Hormones
1.2.6 Vaccines
1.2.7 Insulin
1.2.8 Others
1.3 Market by Application
1.3.1 Global Biopharmaceutical Contract Manufacturing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Autoimmune Diseases
1.3.3 Oncology
1.3.4 Metabolic Diseases
1.3.5 Ophthalmology
1.3.6 Cardiovascular Diseases
1.3.7 Infectious Diseases
1.3.8 Neurology
1.3.9 Respiratory Disorders
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Contract Manufacturing Market Perspective (2017-2028)
2.2 Biopharmaceutical Contract Manufacturing Growth Trends by Region
2.2.1 Biopharmaceutical Contract Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biopharmaceutical Contract Manufacturing Historic Market Size by Region (2017-2022)
2.2.3 Biopharmaceutical Contract Manufacturing Forecasted Market Size by Region (2023-2028)
2.3 Biopharmaceutical Contract Manufacturing Market Dynamics
2.3.1 Biopharmaceutical Contract Manufacturing Industry Trends
2.3.2 Biopharmaceutical Contract Manufacturing Market Drivers
2.3.3 Biopharmaceutical Contract Manufacturing Market Challenges
2.3.4 Biopharmaceutical Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue
3.1.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue (2017-2022)
3.1.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Players (2017-2022)
3.2 Global Biopharmaceutical Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing Revenue
3.4 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio
3.4.1 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing Revenue in 2021
3.5 Biopharmaceutical Contract Manufacturing Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
3.7 Date of Enter into Biopharmaceutical Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical Contract Manufacturing Breakdown Data by Type
4.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Type (2017-2022)
4.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2023-2028)
5 Biopharmaceutical Contract Manufacturing Breakdown Data by Application
5.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Application (2017-2022)
5.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
6.2 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
6.3 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
7.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
7.3 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
8.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
8.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
9.2 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
9.3 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
10.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
10.3 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Lonza Group
11.1.1 Lonza Group Company Detail
11.1.2 Lonza Group Business Overview
11.1.3 Lonza Group Biopharmaceutical Contract Manufacturing Introduction
11.1.4 Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.1.5 Lonza Group Recent Development
11.2 Baxter Biopharma Solutions
11.2.1 Baxter Biopharma Solutions Company Detail
11.2.2 Baxter Biopharma Solutions Business Overview
11.2.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Introduction
11.2.4 Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.2.5 Baxter Biopharma Solutions Recent Development
11.3 Samsung
11.3.1 Samsung Company Detail
11.3.2 Samsung Business Overview
11.3.3 Samsung Biopharmaceutical Contract Manufacturing Introduction
11.3.4 Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.3.5 Samsung Recent Development
11.4 Fujifilm Diosynth Biotechnologies
11.4.1 Fujifilm Diosynth Biotechnologies Company Detail
11.4.2 Fujifilm Diosynth Biotechnologies Business Overview
11.4.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Introduction
11.4.4 Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.4.5 Fujifilm Diosynth Biotechnologies Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Introduction
11.5.4 Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Patheon
11.6.1 Patheon Company Detail
11.6.2 Patheon Business Overview
11.6.3 Patheon Biopharmaceutical Contract Manufacturing Introduction
11.6.4 Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.6.5 Patheon Recent Development
11.7 Rentschler Biotechnologie
11.7.1 Rentschler Biotechnologie Company Detail
11.7.2 Rentschler Biotechnologie Business Overview
11.7.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Introduction
11.7.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.7.5 Rentschler Biotechnologie Recent Development
11.8 Biomeva
11.8.1 Biomeva Company Detail
11.8.2 Biomeva Business Overview
11.8.3 Biomeva Biopharmaceutical Contract Manufacturing Introduction
11.8.4 Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.8.5 Biomeva Recent Development
11.9 Probiogen
11.9.1 Probiogen Company Detail
11.9.2 Probiogen Business Overview
11.9.3 Probiogen Biopharmaceutical Contract Manufacturing Introduction
11.9.4 Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.9.5 Probiogen Recent Development
11.10 Cytovance Biologics
11.10.1 Cytovance Biologics Company Detail
11.10.2 Cytovance Biologics Business Overview
11.10.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Introduction
11.10.4 Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.10.5 Cytovance Biologics Recent Development
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Detail
11.11.2 KBI Biopharma Business Overview
11.11.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Introduction
11.11.4 KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.11.5 KBI Biopharma Recent Development
11.12 WuXi Biologics
11.12.1 WuXi Biologics Company Detail
11.12.2 WuXi Biologics Business Overview
11.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Introduction
11.12.4 WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.12.5 WuXi Biologics Recent Development
11.13 Abzena
11.13.1 Abzena Company Detail
11.13.2 Abzena Business Overview
11.13.3 Abzena Biopharmaceutical Contract Manufacturing Introduction
11.13.4 Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.13.5 Abzena Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Growth Factors
Table 3. Key Players of Interferons
Table 4. Key Players of Monoclonal Antibodies
Table 5. Key Players of Recombinant Hormones
Table 6. Key Players of Vaccines
Table 7. Key Players of Insulin
Table 8. Key Players of Others
Table 9. Global Biopharmaceutical Contract Manufacturing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Biopharmaceutical Contract Manufacturing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Biopharmaceutical Contract Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Biopharmaceutical Contract Manufacturing Market Share by Region (2017-2022)
Table 13. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Biopharmaceutical Contract Manufacturing Market Share by Region (2023-2028)
Table 15. Biopharmaceutical Contract Manufacturing Market Trends
Table 16. Biopharmaceutical Contract Manufacturing Market Drivers
Table 17. Biopharmaceutical Contract Manufacturing Market Challenges
Table 18. Biopharmaceutical Contract Manufacturing Market Restraints
Table 19. Global Biopharmaceutical Contract Manufacturing Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Biopharmaceutical Contract Manufacturing Market Share by Players (2017-2022)
Table 21. Global Top Biopharmaceutical Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2021)
Table 22. Ranking of Global Top Biopharmaceutical Contract Manufacturing Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Biopharmaceutical Contract Manufacturing Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
Table 26. Date of Enter into Biopharmaceutical Contract Manufacturing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2017-2022)
Table 30. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2023-2028)
Table 32. Global Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Application (2017-2022)
Table 34. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Application (2023-2028)
Table 36. North America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 39. Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 40. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 41. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2023-2028) & (US$ Million)
Table 42. Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 43. Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 44. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 45. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 46. Lonza Group Company Detail
Table 47. Lonza Group Business Overview
Table 48. Lonza Group Biopharmaceutical Contract Manufacturing Product
Table 49. Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 50. Lonza Group Recent Development
Table 51. Baxter Biopharma Solutions Company Detail
Table 52. Baxter Biopharma Solutions Business Overview
Table 53. Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Product
Table 54. Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 55. Baxter Biopharma Solutions Recent Development
Table 56. Samsung Company Detail
Table 57. Samsung Business Overview
Table 58. Samsung Biopharmaceutical Contract Manufacturing Product
Table 59. Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 60. Samsung Recent Development
Table 61. Fujifilm Diosynth Biotechnologies Company Detail
Table 62. Fujifilm Diosynth Biotechnologies Business Overview
Table 63. Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Product
Table 64. Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 65. Fujifilm Diosynth Biotechnologies Recent Development
Table 66. Boehringer Ingelheim Company Detail
Table 67. Boehringer Ingelheim Business Overview
Table 68. Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Product
Table 69. Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 70. Boehringer Ingelheim Recent Development
Table 71. Patheon Company Detail
Table 72. Patheon Business Overview
Table 73. Patheon Biopharmaceutical Contract Manufacturing Product
Table 74. Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 75. Patheon Recent Development
Table 76. Rentschler Biotechnologie Company Detail
Table 77. Rentschler Biotechnologie Business Overview
Table 78. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Product
Table 79. Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 80. Rentschler Biotechnologie Recent Development
Table 81. Biomeva Company Detail
Table 82. Biomeva Business Overview
Table 83. Biomeva Biopharmaceutical Contract Manufacturing Product
Table 84. Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 85. Biomeva Recent Development
Table 86. Probiogen Company Detail
Table 87. Probiogen Business Overview
Table 88. Probiogen Biopharmaceutical Contract Manufacturing Product
Table 89. Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 90. Probiogen Recent Development
Table 91. Cytovance Biologics Company Detail
Table 92. Cytovance Biologics Business Overview
Table 93. Cytovance Biologics Biopharmaceutical Contract Manufacturing Product
Table 94. Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 95. Cytovance Biologics Recent Development
Table 96. KBI Biopharma Company Detail
Table 97. KBI Biopharma Business Overview
Table 98. KBI Biopharma Biopharmaceutical Contract ManufacturingProduct
Table 99. KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 100. KBI Biopharma Recent Development
Table 101. WuXi Biologics Company Detail
Table 102. WuXi Biologics Business Overview
Table 103. WuXi Biologics Biopharmaceutical Contract ManufacturingProduct
Table 104. WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 105. WuXi Biologics Recent Development
Table 106. Abzena Company Detail
Table 107. Abzena Business Overview
Table 108. Abzena Biopharmaceutical Contract ManufacturingProduct
Table 109. Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 110. Abzena Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical Contract Manufacturing Market Share by Type: 2021 VS 2028
Figure 2. Growth Factors Features
Figure 3. Interferons Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Recombinant Hormones Features
Figure 6. Vaccines Features
Figure 7. Insulin Features
Figure 8. Others Features
Figure 9. Global Biopharmaceutical Contract Manufacturing Market Share by Application in 2021 & 2028
Figure 10. Autoimmune Diseases Case Studies
Figure 11. Oncology Case Studies
Figure 12. Metabolic Diseases Case Studies
Figure 13. Ophthalmology Case Studies
Figure 14. Cardiovascular Diseases Case Studies
Figure 15. Infectious Diseases Case Studies
Figure 16. Neurology Case Studies
Figure 17. Respiratory Disorders Case Studies
Figure 18. Others Case Studies
Figure 19. Biopharmaceutical Contract Manufacturing Report Years Considered
Figure 20. Global Biopharmaceutical Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 21. Global Biopharmaceutical Contract Manufacturing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 22. Global Biopharmaceutical Contract Manufacturing Market Share by Region: 2021 VS 2028
Figure 23. Global Biopharmaceutical Contract Manufacturing Market Share by Players in 2021
Figure 24. Global Top Biopharmaceutical Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2021)
Figure 25. The Top 10 and 5 Players Market Share by Biopharmaceutical Contract Manufacturing Revenue in 2021
Figure 26. North America Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. North America Biopharmaceutical Contract Manufacturing Market Share by Country (2017-2028)
Figure 28. United States Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Canada Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Europe Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Europe Biopharmaceutical Contract Manufacturing Market Share by Country (2017-2028)
Figure 32. Germany Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. France Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. U.K. Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Italy Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Russia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Nordic Countries Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Share by Region (2017-2028)
Figure 40. China Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Latin America Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Latin America Biopharmaceutical Contract Manufacturing Market Share by Country (2017-2028)
Figure 48. Mexico Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Share by Country (2017-2028)
Figure 52. Turkey Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Lonza Group Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 55. Baxter Biopharma Solutions Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 56. Samsung Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 57. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 58. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 59. Patheon Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 60. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 61. Biomeva Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 62. Probiogen Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 63. Cytovance Biologics Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 64. KBI Biopharma Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 65. WuXi Biologics Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 66. Abzena Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs